ArticleToxicology2016

Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.

Nikita Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.